Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

European urology - 1 Mar 2020

Ploussard Guillaume

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androstenes
Share to Benzamides
Share to Mutation
Share to Nitriles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostatic Neoplasms, Castration-Resistant

Source

Identifiers

PMID: 31727449
DOI: 10.1016/j.eururo.2019.10.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.PMID 31727449Read ↗

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.Semantic proximity Read ↗

Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone TreatmentSemantic proximity Read ↗

A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509Semantic proximity Read ↗

Wnt Signaling and Drug Resistance in Cancer.Semantic proximity Read ↗

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.Semantic proximity Read ↗

Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer.Semantic proximity Read ↗

WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Semantic proximity Read ↗

Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cellsSemantic proximity Read ↗

WNT SIGNALING IN PROSTATE DEVELOPMENT AND CARCINOGENESISSemantic proximity Read ↗

Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy.Semantic proximity Read ↗

Overcoming mutation-based resistance to antiandrogens with rational drug design.Semantic proximity Read ↗

Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.